Jingming Capital logo

Jingming Capital

Asia, Shandong, China, Qingdao Shi

Description

Jingming Capital is an investment firm.

Investor Profile

Jingming Capital has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (67%)
  • Series D (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Health Care
  • Medical Device
  • Aerospace
  • Space Travel
  • Transportation
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jingming Capital frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
PICC Capital Investment Management
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Cedarlake Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
China Life Investment Holding
Asia, Beijing, China, Beijing
Co-Investments: 1
Honghui Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CE
Asia, Fujian, China, Xiamen
Co-Investments: 1
LC
North America, Washington, United States, Vancouver
Co-Investments: 1
Jiantou Huawen Investment
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Jingming Capital?

iSpace China

Beijing, Beijing, China

iSpace designs and develops commercial space shuttle.

AerospaceSpace TravelTransportation
Series CSep 6, 2024
Amount Raised: $98,745,927
Tongxin Medical Equipment

Suzhou, Jiangsu, China

Tongxin Medical Equipment is an artificial-heart maker company.

Biotechnology
Series DJan 25, 2022
Amount Raised: $100,000,000
SiBionics

Shenzhen, Guangdong, China

SiBionics is a medtech company that engages in the field of chronic disease management.

Artificial Intelligence (AI)Health CareMedical Device
Series CJan 21, 2022
Amount Raised: $126,000,000